We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

Back to rankings

0 hedge funds and large institutions have $0 invested in Foundation Medicine, Inc. in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 156 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 157 → 0 (-157)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $1.86B → $0 (-$1.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 156

Holders
–
Holders Change
-157
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
156
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$200M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$183M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$175M
4
State Street
State Street
Massachusetts
-$119M
5
Chevy Chase Trust
Chevy Chase Trust
Maryland
-$111M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
26
Jennison Associates
New York
– -$17.3M -126,761 Closed
BA
27
Boston Advisors
Massachusetts
– -$17.1M -124,918 Closed
ACM
28
Adalta Capital Management
New York
– -$16.9M -123,451 Closed
CCM
29
Chicago Capital Management
Illinois
– -$16.8M -123,102 Closed
TA
30
Teachers Advisors
New York
– -$14.8M -108,035 Closed
GCIA
31
Gabelli & Co Investment Advisers
New York
– -$13.8M -101,070 Closed
Macquarie Group
32
Macquarie Group
Australia
– -$13.7M -100,011 Closed
WRBC
33
W.R. Berkley Corp
Connecticut
– -$13.3M -97,584 Closed
COPPSERS
34
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$12.5M -91,241 Closed
ZDA
35
Zweig-DiMenna Associates
New York
– -$11.9M -87,030 Closed
Invesco
36
Invesco
Georgia
– -$11.6M -85,090 Closed
EPM
37
Equitec Proprietary Markets
Illinois
– -$11.6M -84,943 Closed
PC
38
Pier Capital
Connecticut
– -$11.4M -83,100 Closed
Charles Schwab
39
Charles Schwab
California
– -$10.9M -79,831 Closed
Bank of New York Mellon
40
Bank of New York Mellon
New York
– -$9.33M -68,277 Closed
CS
41
Credit Suisse
Switzerland
– -$7.79M -56,974 Closed
LIM
42
Longfellow Investment Management
Massachusetts
– -$7.27M -53,205 Closed
GH
43
GAM Holding
Switzerland
– -$7M -51,200 Closed
Two Sigma Investments
44
Two Sigma Investments
New York
– -$6.95M -50,816 Closed
First Trust Advisors
45
First Trust Advisors
Illinois
– -$6.75M -49,357 Closed
AllianceBernstein
46
AllianceBernstein
Tennessee
– -$5.75M -42,088 Closed
NIM
47
Needham Investment Management
New York
– -$5.47M -40,000 Closed
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
– -$4.96M -36,300 Closed
PP
49
Paloma Partners
Connecticut
– -$4.82M -35,220 Closed
Wolverine Trading
50
Wolverine Trading
Illinois
– -$2.74M -34,819 Closed
1
2
3 4 5

FMI Hedge Fund Activity: Q3 2018 in Review

0 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q3 2018, worth a combined $0 — down 100% from $1.86B a quarter earlier.

Sellers outnumbered buyers: 156 funds closed out of FMI and 0 opened new positions — a net loss of 156 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $200M sold.

  • 0 institutional investors held Foundation Medicine, Inc. (FMI) as of Q3 2018, down from 157 in Q2 2018.
  • Funds reported $0 of Foundation Medicine, Inc. stock for Q3 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Foundation Medicine, Inc. positions in Q3 2018 and 156 closed out, a net change of -156 holders.
  • The largest Foundation Medicine, Inc. seller in Q3 2018 was BlackRock, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2018.